Combination chemotherapy with irinotecan and gemcitabine for taxane/platinum-resistant/refractory ovarian and primary peritoneal cancer: a multicenter phase I/II trial (GOGO-Ov 6).
about
Combination chemotherapy with irinotecan and gemcitabine for taxane/platinum-resistant/refractory ovarian and primary peritoneal cancer: a multicenter phase I/II trial (GOGO-Ov 6).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Combination chemotherapy with ...... phase I/II trial (GOGO-Ov 6).
@en
Combination chemotherapy with ...... a multicenter phase I/II trial
@nl
type
label
Combination chemotherapy with ...... phase I/II trial (GOGO-Ov 6).
@en
Combination chemotherapy with ...... a multicenter phase I/II trial
@nl
prefLabel
Combination chemotherapy with ...... phase I/II trial (GOGO-Ov 6).
@en
Combination chemotherapy with ...... a multicenter phase I/II trial
@nl
P2093
P2860
P1476
Combination chemotherapy with ...... phase I/II trial (GOGO-Ov 6).
@en
P2093
Akinori Wakimoto
Eiji Kobayashi
Kae Hashimoto
Kazushige Adachi
Kenjiro Sawada
Kiyoshi Yoshino
Masahiko Takemura
Masami Fujita
Ruriko Nakae
Seiji Mabuchi
P2860
P2888
P304
P356
10.1007/S00280-017-3468-5
P577
2017-10-28T00:00:00Z